Dialogue Health Technologies (TSE:CARE – Get Rating) had its price objective lowered by equities research analysts at Scotiabank from C$8.00 to C$5.50 in a research note issued to investors on Wednesday, BayStreet.CA reports. Scotiabank’s price target would indicate a potential upside of 69.23% from the stock’s previous close.
Several other brokerages also recently issued reports on CARE. TD Securities decreased their target price on Dialogue Health Technologies from C$4.50 to C$3.50 and set a “hold” rating on the stock in a research note on Wednesday, September 21st. Canaccord Genuity Group lowered their target price on shares of Dialogue Health Technologies from C$6.00 to C$5.00 in a report on Wednesday. CIBC cut their target price on shares of Dialogue Health Technologies from C$4.00 to C$3.50 and set a “neutral” rating for the company in a research note on Wednesday, October 12th. Royal Bank of Canada decreased their price target on shares of Dialogue Health Technologies from C$6.00 to C$5.00 and set a “sector perform” rating on the stock in a research note on Friday, September 23rd. Finally, National Bankshares dropped their price objective on shares of Dialogue Health Technologies from C$11.50 to C$8.50 and set an “outperform” rating for the company in a report on Tuesday, August 9th.
Dialogue Health Technologies Stock Performance
Shares of CARE stock opened at C$3.25 on Wednesday. The business has a fifty day simple moving average of C$2.69. Dialogue Health Technologies has a 52-week low of C$2.17 and a 52-week high of C$8.85. The stock has a market cap of C$214.54 million and a price-to-earnings ratio of 7.39. The company has a debt-to-equity ratio of 2.73, a current ratio of 4.10 and a quick ratio of 3.91.
Dialogue Health Technologies Company Profile
Dialogue Health Technologies Inc operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists.
- Does ASML’s November Rally Have Staying Power?
- Verra Mobility Stock Has Returned Back to the Station
- Is Advance Auto Parts a Buy After its Earnings Crash?
- BJ’s Wholesale Club: Beware The Sell-Side
- The Next Catalyst For Mullen Automotive Stock Is December 23rd
Receive News & Ratings for Dialogue Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dialogue Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.